Nagashima K, Fukushima H, Shimizu K, Yamada A, Hidaka M, Hasumi H, et al. Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression. Oncotarget. 2017;8:9947-9960 pubmed publisher

Vosper J, Masuccio A, Kullmann M, Ploner C, Geley S, Hengst L. Statin-induced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation. Oncotarget. 2015;6:2889-902 pubmed

Tsai Y, Lai C, Lai C, Chang K, Wu K, Tseng S, et al. The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth. Oncotarget. 2014;5:6425-36 pubmed

Cheng H, Meng J, Wang G, Meng Y, Li Y, Wei D, et al. Skp2 regulates subcellular localization of PPAR? by MEK signaling pathways in human breast cancer. Int J Mol Sci. 2013;14:16554-69 pubmed publisher

Kullmann M, Grubbauer C, Goetsch K, Jakel H, Podmirseg S, Trockenbacher A, et al. The p27-Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T-lymphoma cells. Cell Cycle. 2013;12:2625-35 pubmed publisher

Meng J, Ding Y, Shen A, Yan M, He F, Ji H, et al. Overexpression of PPAR? can down-regulate Skp2 expression in MDA-MB-231 breast tumor cells. Mol Cell Biochem. 2010;345:171-80 pubmed publisher

Li X, Cai L, Chen H, Zhang Q, Zhang S, Wang Y, et al. Inhibitor of growth 4 induces growth suppression and apoptosis in glioma U87MG. Pathobiology. 2009;76:181-92 pubmed publisher